Publications (1)1.99 Total impact
-
Article: Gadofosveset-enhanced magnetic resonance angiography as a means of evaluating pulmonary arteriovenous malformation: a case report.
[show abstract] [hide abstract]
ABSTRACT: This case report is a unique presentation of a new potential indication for Gadofosvest (Ablavar), a blood pool contrast agent for magnetic resonance angiography (MRA). Ablavar is an excellent MRA contrast agent because it provides optimal contrast opacification of both the arterial and venous system, unlike the conventional extracellular agents that are used for arterial imaging only. The present case report demonstrates the ability of Ablavar to demonstrate pulmonary arteriovenous malformation (AVM), showing both its arterial feeders as well as its venous drainage tract.Magnetic Resonance Imaging 04/2012; 30(6):886-8. · 1.99 Impact Factor
Top co-authors
Top Journals
Institutions
-
2012
-
Montreal Heart Institute
Montréal, Quebec, Canada
-
